WHO recommends long-lasting cabotegravir for HIV prevention

News Release by World Health Organization  WHO on 28/07/22 released new guidelines for the use of long-acting injectable cabotegravir (CAB-LA) as pre-exposure prophylaxis (PrEP) for HIV and called for countries to consider this safe and highly effective prevention option for people at substantial risk of

World AIDS Day- Impact of COVID-19 on ending the HIV/AIDS epidemic

It is nearly 40 years since the first reported case of HIV/AIDS. The 32nd edition of the World AIDS Day was commemorated under an unprecedented norm occasioned by the COVID-19 pandemic. Over and above the adverse socio-economic impact that has been brought about as a